With all the news and emphasis on miraculous stage 4 cancer treatment stories through the use of cannabinoids, the cancer-prevention aspect of revolutionary low-dose Dharmanol (as opposed to high dose) has received short shrift. Dharmanol strengthens the human body's built-in endo-cannabinoid system, a system that plays an important role in supporting the immune system among other health-sustaining functions.

The key to cannabinoids as treatment for Stage 4 cancer is reportedly their ability to stop replication of cancer cells (and their continuing spread to other parts of the body). The spread of cancer cells to other organs is the hallmark of Stage 4 cancer. Once replication stops, the malignant tumors shrink and eventually are absorbed or can be removed.

It's said even healthy persons have stray cancer cells, but a strong immune system disallows multiplication of these errant cells. The body's built-in endo-cannabinoid system apparently plays a role in this response. With Dharmanol strengthening the endo-cannabinoid system, think of the hundreds of milllions of people who would take a low-dose Dhamamanol cancer-prevention tablet every day like they would take a one-a-day multiple vitamin. No side effects, perfectly safe.

This is bigger than big.